Exploratory study of an anti-PD-L1/TGF-β antibody, TQB2858, in patients with refractory or recurrent osteosarcoma and alveolar soft part sarcoma: a report from Chinese sarcoma study group (TQB2858-Ib-02)

BACKGROUND: Novel and effective immunotherapies are required for refractory or recurrent sarcomas. Transforming growth factor-beta (TGF-β) is a diverse regulatory and fibrogenic protein expressed in multiple sarcoma tumors that promotes epithelial-mesenchymal transition and excessive deposition of e...

Descripción completa

Detalles Bibliográficos
Autores principales: Xie, Lu, Liang, Xin, Xu, Jie, Sun, Xin, Liu, Kuisheng, Sun, Kunkun, Li, Yuan, Tang, Xiaodong, Li, Xianan, Zhan, Xing, Niu, Xiaohui, Guo, Wei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10503089/
https://www.ncbi.nlm.nih.gov/pubmed/37715133
http://dx.doi.org/10.1186/s12885-023-11390-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10503089/
https://www.ncbi.nlm.nih.gov/pubmed/37715133
http://dx.doi.org/10.1186/s12885-023-11390-4

Ejemplares similares